FDA Approves Thyrogen® For Use In Thyroid Cancer Ablation
(December 17, 2007)
Genzyme Corp. announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental indication for Thyrogen® (thyrotropin alfa for injection) to be used in combination with radioiodine to ablate, or destroy, the remaining thyroid tissue in patients who have had their cancerous thyroids removed.
